Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Total Liabilities (2016 - 2026)

Biomerica's Total Liabilities history spans 16 years, with the latest figure at $1.6 million for Q1 2026.

  • Quarterly results put Total Liabilities at $1.6 million for Q1 2026, down 15.26% from a year ago — trailing twelve months through Feb 2026 was $1.6 million (down 15.26% YoY), and the annual figure for FY2025 was $1.8 million, down 30.9%.
  • Total Liabilities for Q1 2026 was $1.6 million at Biomerica, down from $1.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.8 million in Q1 2022 to a low of $1.6 million in Q1 2026.
  • The 5-year median for Total Liabilities is $2.5 million (2023), against an average of $2.6 million.
  • The sharpest move saw Total Liabilities soared 183.92% in 2022, then tumbled 71.5% in 2023.
  • Year by year, Total Liabilities stood at $2.7 million in 2022, then decreased by 8.13% to $2.4 million in 2023, then decreased by 11.76% to $2.2 million in 2024, then fell by 25.97% to $1.6 million in 2025, then fell by 2.38% to $1.6 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $1.6 million, $1.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.